Ambrx Biopharma, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2022 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Ambrx Biopharma, Inc. quarterly Net Income (Loss) Attributable to Parent history and growth rate from Q3 2022 to Q3 2023.
  • Ambrx Biopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$23M, a 47.7% decline year-over-year.
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$23M -$7.42M -47.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q3 2022 -$15.6M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.